Publications by authors named "Martinus Capelle"

Claim this Profile
I
Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena.
Tao Ju Cui, Max Beugeling, Wallace Kaserer, Anton J P van Heugten, Martinus A H Capelle

Eur J Pharm Biopharm· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.
Maarten Swart, Harmjan Kuipers, Fin Milder, Mandy Jongeneelen, Tina Ritschel, Martinus Capelle

NPJ Vaccines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Michael Moeller's spirit.
Florence Delie, Martinus A H Capelle

Eur J Pharm Biopharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine.
Martinus A H Capelle, Lara Babich, J P Els van Deventer-Troost, Doris Salerno, Kelly Krijgsman

Eur J Pharm Biopharm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput formulation screening of therapeutic proteins.
Martinus A H Capelle, Tudor Arvinte

Drug Discov Today Technol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish.
Verena Christen, Martinus Capelle, Karl Fent

Toxicol Appl Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
Filippo Mulinacci, Emilie Poirier, Martinus A H Capelle, Robert Gurny, Tudor Arvinte

Eur J Pharm Biopharm· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab).
Bas J M Peters, Martinus A H Capelle, Tudor Arvinte, Ewoudt M W van de Garde

MAbs· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncovalent PEGylation: different effects of dansyl-, L-tryptophan-, phenylbutylamino-, benzyl- and cholesteryl-PEGs on the aggregation of salmon calcitonin and lysozyme.
Claudia Mueller, Martinus A H Capelle, Emek Seyrek, Sophie Martel, Pierre-Alain Carrupt

J Pharm Sci· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation.
Claudia Mueller, Martinus A H Capelle, Tudor Arvinte, Emek Seyrek, Gerrit Borchard

Eur J Pharm Biopharm· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced physical stability of human calcitonin after methionine oxidation.
Filippo Mulinacci, Emilie Poirier, Martinus A H Capelle, Robert Gurny, Tudor Arvinte

Eur J Pharm Biopharm· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitonin.
Claudia Mueller, Martinus A H Capelle, Tudor Arvinte, Emek Seyrek, Gerrit Borchard

J Pharm Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of human growth hormone: influence of methionine oxidation on thermal folding.
Filippo Mulinacci, Martinus A H Capelle, Robert Gurny, Alex F Drake, Tudor Arvinte

J Pharm Sci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidized recombinant human growth hormone that maintains conformational integrity.
Filippo Mulinacci, Steven E J Bell, Martinus A H Capelle, Robert Gurny, Tudor Arvinte

J Pharm Sci· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2).
Ludmila Luca, Martinus A H Capelle, Gia Machaidze, Tudor Arvinte, Olivier Jordan

Int J Pharm· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high throughput protein formulation platform: case study of salmon calcitonin.
Martinus A H Capelle, Robert Gurny, Tudor Arvinte

Pharm Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput methods to characterize protein permeation and release.
Martinus A H Capelle, Robert Gurny, Tudor Arvinte

Int J Pharm· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput screening of protein formulation stability: practical considerations.
Martinus A H Capelle, Robert Gurny, Tudor Arvinte

Eur J Pharm Biopharm· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
Martinus A H Capelle, Peter Brügger, Tudor Arvinte

Vaccine· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis